Monthly Prescribing Reference29d
Ustekinumab Biosimilars Pyzchiva, Selarsdi, and Yesintek Now Available
Ustekinumab is a human interleukin-12 and ... Pyzchiva is supplied as a 45mg/0.5mL and a 90mg/mL single-dose prefilled syringe for subcutaneous (SC) injection, and a 130mg/26mL single-dose ...
Center for Biosimilars12d
More Ustekinumab Biosimilars Join US Market Share Fight
Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...
The Victoria Advocate13d
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
It encompasses all indications approved for the STELARA ® reference product ... 45mg/0.5 mL or 90mg/1 mL solution in a single-dose, prefilled syringe. The intravenous infusion is provided ...
Business Wire22d
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi ® (ustekinumab-aauz)
Otulfi ® is an ustekinumab biosimilar for the reference ... a 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL (5 mg/mL) single dose vial for IV infusion.
Stockhouse13d
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
It encompasses all indications approved for the STELARA® reference product ... 45mg/0.5 mL or 90mg/1 mL solution in a single-dose, prefilled syringe. The intravenous infusion is provided as a ...
Yahoo Finance13d
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition cost (WAC) list price at an 85% discount to the current WAC list price of STELARA ...